DAVITA INC (DVA) Stock Price & Overview
NYSE:DVA • US23918K1088
Current stock price
The current stock price of DVA is 149.31 USD. Today DVA is down by -0.3%. In the past month the price decreased by -0.94%. In the past year, price increased by 0.78%.
DVA Key Statistics
- Market Cap
- 9.974B
- P/E
- 14.37
- Fwd P/E
- 10.56
- EPS (TTM)
- 10.39
- Dividend Yield
- N/A
DVA Stock Performance
DVA Stock Chart
DVA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to DVA. When comparing the yearly performance of all stocks, DVA is one of the better performing stocks in the market, outperforming 80.69% of all stocks.
DVA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DVA. While DVA has a great profitability rating, there are quite some concerns on its financial health.
DVA Earnings
On February 2, 2026 DVA reported an EPS of 3.4 and a revenue of 3.62B. The company beat EPS expectations (6.68% surprise) and beat revenue expectations (2.49% surprise).
DVA Forecast & Estimates
14 analysts have analysed DVA and the average price target is 154.54 USD. This implies a price increase of 3.51% is expected in the next year compared to the current price of 149.31.
For the next year, analysts expect an EPS growth of 36.12% and a revenue growth 3.8% for DVA
DVA Groups
Sector & Classification
DVA Financial Highlights
Over the last trailing twelve months DVA reported a non-GAAP Earnings per Share(EPS) of 10.39. The EPS increased by 9.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.47% | ||
| ROA | 4.27% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
DVA Ownership
DVA Latest News, Press Relases and Analysis
DVA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 9.86 | 90.938B | ||
| CI | THE CIGNA GROUP | 8.41 | 69.3B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 98.65 | 26.318B | ||
| LH | LABCORP HOLDINGS INC | 14.4 | 21.671B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.18 | 21.453B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.173B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.72 | 7.928B | ||
| CHE | CHEMED CORP | 15.59 | 5.205B | ||
| HIMS | HIMS & HERS HEALTH INC | 40.32 | 5.019B | ||
| RDNT | RADNET INC | 77.29 | 4.772B | ||
| OPCH | OPTION CARE HEALTH INC | 14.76 | 4.406B | ||
| BLLN | BILLIONTOONE INC CL A | 264.57 | 3.494B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About DVA
Company Profile
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Company Info
IPO: 1995-10-31
DAVITA INC
2000 16th St
Denver COLORADO 80202 US
CEO: Javier J. Rodriguez
Employees: 78000
Phone: 13105362668
DAVITA INC / DVA FAQ
What does DAVITA INC do?
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
What is the stock price of DAVITA INC today?
The current stock price of DVA is 149.31 USD. The price decreased by -0.3% in the last trading session.
What is the dividend status of DAVITA INC?
DVA does not pay a dividend.
What is the ChartMill technical and fundamental rating of DVA stock?
DVA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the PE ratio for DVA stock?
The PE ratio for DAVITA INC (DVA) is 14.37. This is based on the reported non-GAAP earnings per share of 10.39 and the current share price of 149.31 USD.
How many employees does DAVITA INC have?
DAVITA INC (DVA) currently has 78000 employees.
What is DAVITA INC worth?
DAVITA INC (DVA) has a market capitalization of 9.97B USD. This makes DVA a Mid Cap stock.